Organon (OGN) FCF Margin (2020 - 2026)

Organon (OGN) posted quarterly FCF Margin of 12.88% for Q1 2026, up 1003.0% year-over-year from 1.17% in Q1 2025, and up 102.14% on a QoQ basis from 6.37% in Q4 2025.

Organon (OGN) FCF Margin (2020 - 2026) Analysis & Trends

Organon (OGN) has reported FCF Margin for 7 consecutive years, with 12.88% the latest figure, recorded in Q1 2026.

  • In Q1 2026, FCF Margin rose 1003.0% year-over-year to 12.88%; the TTM figure through Mar 2026 stood at 11.08% (down 126.0% YoY), while the FY2025 annual figure was 8.66%, down 328.0% from the prior year.
  • FCF Margin came in at 12.88% for Q1 2026 at Organon, up from 6.37% in the prior quarter.
  • The five-year high for FCF Margin was 21.04% in Q4 2024, with the low at 2.74% in Q2 2023.
  • Average FCF Margin over 5 years is 10.19%, with a median of 11.36% recorded in 2025.
  • Across the five-year window, FCF Margin sank 7805 bps in 2022 and surged 2140 bps in 2024, its largest moves.
  • Year by year, FCF Margin stood at 13.74% in 2022, then soared by 45 bps to 19.9% in 2023, then rose by 6 bps to 21.04% in 2024, then tumbled by 70 bps to 6.37% in 2025, then surged by 102 bps to 12.88% in 2026.
  • According to Business Quant data, FCF Margin over the past three periods registered 12.88%, 6.37%, and 13.61% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 15.19%
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 6.09%
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 23.76%
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 3.80%
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 17.97%
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 17.14%
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 34.87%
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 93.16%
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn 12.88%

Historic Data

Download Data
DateValue
Mar 31, 2026 12.88%
Dec 31, 2025 6.37%
Sep 30, 2025 13.61%
Jun 30, 2025 11.36%
Mar 31, 2025 2.84%
Dec 31, 2024 21.04%
Sep 30, 2024 6.26%
Jun 30, 2024 18.67%
Mar 31, 2024 1.85%
Dec 31, 2023 19.90%
Sep 30, 2023 13.56%
Jun 30, 2023 -2.74%
Mar 31, 2023 4.42%
Dec 31, 2022 13.74%
Sep 30, 2022 17.05%
Jun 30, 2022 6.69%
Mar 31, 2022 5.74%
Dec 31, 2021 -0.75%
Sep 30, 2021 20.75%
Jun 30, 2021 24.20%